SADS Externally-led Patient Focused Drug Development
June 20, 2023
“Patient-focused drug development (PFDD) is a systematic approach to help ensure that patients’ experiences, perspectives, needs, and priorities are captured and meaningfully incorporated into drug development and evaluation. … As experts in what it is like to live with their condition, patients are uniquely positioned to inform the understanding of the therapeutic context for drug development and evaluation.”
Your voice matters
Thank you to all who attended our EL-PFDD for ARVC meeting on June 20, 2023! You can register below to watch the recording of the EL-PFDD and view the Voice of the Patient report.
What is an Externally-Led Patient-Focused Drug Development meeting?
Externally-Led Patient-Focused Drug Development (EL-PFDD) meetings give the Food and Drug Administration (FDA) and other key stakeholders — including researchers, biopharma companies, healthcare providers, product developers and federal regulatory partners — an important opportunity to hear directly from patients, their families, caregivers, and patient advocates about the symptoms that matter most to them, the impact the disease has on patients’ daily lives, patients’ experiences with currently available treatments, and patient’s priorities for therapeutic outcomes. These inputs may also inform FDA’s decisions and oversight both during drug development and their reviews of marketing applications for new therapies.
What happens during the meeting?
The meeting and participants, will be virtual. However, the hosts and co-moderators will be looking for the ARVC community to participate in polls, by sending in comments, or calling in live! There will be a brief 10-15 minute overview of ARVC by a clinical expert, followed by two sessions with patient panelists, callers, reading of submitted comments, and live anonymous polling.
Please plan on viewing and participating in the entire meeting, but if you can only attend part of the meeting, that would also be greatly appreciated. The meeting recording will immediately replace the live feed after the meeting ends.
What happens after the meeting?
The comments and information shared before, during, and after the meeting will be consolidated into a Voice of the Patient report. This report will be publicly available and will be provided to the FDA and to researchers developing new therapies for ARVC.
During the EL-PFDD, you’ll hear from patients and caregivers whose lives have been affected by ARVC tell their stories. Here, you can meet the panelists who will be presenting their stories during these sessions.
ARVC: Stories from the EL-PFDD
FAQ – Frequently Asked Questions
- Is this meeting free? Absolutely – we want all ARVC community members to participate
- Can families outside of the USA participate? Yes – the meeting is open to all ARVC families
- What about families with deceased loved ones? We want and need to hear and learn from you as well.
- Do I need a computer to attend? No, you can participate from your mobile device or tablet – if you can read this web page (and you are right now), you will see the meeting here.
- What will be the primary meeting language? It will be English.
- Will the meeting be recorded? Yes – it will be available immediately after the meeting ends on this page (hosted by YouTube so everyone can easily access it).
Do you have other questions? Please contact us